The Biosimilars Litigation Landscape for 2017

U.S. Biosimilar Litigation News

Law360 has published an article by three of our contributing editors here at Big Molecule Watch.  As suggested by the title, “The Biosimilars Litigation Landscape for 2017,” the article provides an analysis of the expected BPCIA litigation activity, including potential new litigations, in 2017.  Click here for a link to the article.

 

Download PDF

Tagged with 

Comments are closed.